Citation Impact
Citing Papers
Novel selective and potent 5-HT reuptake inhibitors with 5-HT1D antagonist activity: chemistry and pharmacological evaluation of a series of thienopyran derivatives
2004
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Synthetic methods of glycopeptide assembly, and biological analysis of glycopeptide products
1997 StandoutNobel
Functional Gastroduodenal Disorders
2006 Standout
Neural mechanism underlying acupuncture analgesia
2008 Standout
Imidazolones in Diastereoselective Cyclization Reactions and CuII‐Catalysed Cross‐Coupling Reactions
2009 StandoutNobel
Descending control of pain
2002 Standout
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices
1993
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors
1994 StandoutNobel
Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia
2005
Scope and limitations of a DMF bio-alternative within Sonogashira cross-coupling and Cacchi-type annulation
2016
Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist
1992
Polypharmacology of dopamine receptor ligands
2016
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Kinase inhibition in autoimmunity and inflammation
2020
Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: Potential treatment of extrapyramidal side effects
1993 StandoutNobel
Palladium‐Catalyzed Cross‐Coupling: A Historical Contextual Perspective to the 2010 Nobel Prize
2012 Standout
Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants
2012
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Tandem hydroformylation–hydrazone formation–Fischer indole synthesis: a novel approach to tryptamides
2005
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors
2010
Highly Stereoselective Biocatalytic Synthesis of Key Cyclopropane Intermediate to Ticagrelor
2016 StandoutNobel
Constrained glycopeptide ligands for MPRs. Limitations of unprotected phosphorylated building blocks
1997 StandoutNobel
Amino acid derived 1,4‐dialkyl substituted imidazolones
2010 StandoutNobel
Click Chemistry: 1,2,3‐Triazoles as Pharmacophores
2011 Standout
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
2006
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Synthesis, characterization, cellular uptake and interaction with native DNA of a bis(pyridyl)-1,2,4-oxadiazole copper(ii) complex
2010
Treatment of functional dyspepsia
2005
FAK in cancer: mechanistic findings and clinical applications
2014
Attacking pain at its source: new perspectives on opioids
2003
Iron(iii) catalysed synthesis of unsymmetrical di and trisubstituted ureas – a variation of classical Ritter reaction
2012
Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status
2016
Nondopaminergic mechanisms in levodopa‐induced dyskinesia
2005
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
1998
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The blood-brain barrier: Bottleneck in brain drug development
2004 Standout
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
Iron Catalysis in Organic Synthesis
2015 Standout
Synthesis of Organochalcogen Propargyl Aryl Ethers and Their Application in the Electrophilic Cyclization Reaction: An Efficient Preparation of 3-Halo-4-Chalcogen-2H-Benzopyrans
2009
Synthesis and Evaluation of a Set of 4-Phenylpiperidines and 4-Phenylpiperazines as D2Receptor Ligands and the Discovery of the Dopaminergic Stabilizer 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine (Huntexil, Pridopidine, ACR16)
2010
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Iron(III) Chloride/Diorganyl Diselenides‐Promoted Regioselective Cyclization of Alkynyl Aryl Ketones: Synthesis of 3‐Organoselenyl Chromenones under Ambient Atmosphere
2011
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms
1994
Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities
2016
Advances in Transition Metal (Pd,Ni,Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners
2011 Standout
Practical Methodologies for the Synthesis of Indoles
2006 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Synthetic approaches to the 2011 new drugs
2013
Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: kinetics and application
2012
Precise Modulation of CO2 Sorption in Ti8Ce2–Oxo Clusters: Elucidating Lewis Acidity of the Ce Metal Sites and Structural Flexibility
2024 StandoutNobel
Solid-Phase Synthesis of Aryl-Substituted Thienoindolizines: Sequential Pictet−Spengler, Bromination and Suzuki Cross-Coupling Reactions of Thiophenes
2008 StandoutNobel
1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D4Receptor with Excellent Selectivity over Ion Channels
1999
Green and Sustainable Solvents in Chemical Processes
2018 Standout
Marine natural products
2018 Standout
Glycopeptid- und Oligosaccharidbibliotheken
2000 StandoutNobel
Emerging Molecular Approaches to Pain Therapy
1999
Novel Type of Rigid C-Linked Glycosylacetylene−Phenylalanine Building Blocks for Combinatorial Synthesis of C-linked Glycopeptides
1998 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Synthetic Approaches and Pharmacological Activity of 1,3,4-Oxadiazoles: A Review of the Literature from 2000–2012
2012
Catalytic Asymmetric Protonation of Silyl Ketene Imines
2013 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Palladium−Tetraphosphine as Catalyst Precursor for High-Turnover-Number Negishi Cross-Coupling of Alkyl- or Phenylzinc Derivatives with Aryl Bromides
2006
Modulators of Protein–Protein Interactions
2014
Works of Hartmut E. Greiner being referenced
Sarizotan, a serotonin 5-HT 1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile
2004
Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity
2004
2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists
2005
Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist
1991
Fragment-based discovery of focal adhesion kinase inhibitors
2013
A pharmacological profile of the novel, peripherally‐selectivek‐opioid receptor agonist, EMD 61753
1994
Biochemical and functional studies on EMD 49 980: a potent, selectively presynaptic D-2 dopamine agonist with actions on serotonin systems
1989
Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashira coupling–TMS-deprotection–CuAAC sequence
2011
SAR of novel biarylmethylamine dopamine D4 receptor ligands
1998
Structural and Biophysical Characterization of the Syk Activation Switch
2012
Cyclic hexapeptide NK‐2 antagonists
1994
New Selective and Potent 5-HT1B/1DAntagonists: Chemistry and Pharmacological Evaluation ofN-Piperazinylphenyl Biphenylcarboxamides and Biphenylsulfonamides
2000
Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors
2004
Bioisosterism of Fluorine and Cyano as Indole Substituents. Theoretical, in vitro and in vivo Examination
2004
5-HT Reuptake Inhibitors with 5-HT1B/1DAntagonistic Activity: A New Approach toward Efficient Antidepressants
2000
2‐Alkyl‐3‐(1,2,3,6‐tetrahydropyridin‐4‐yl)‐1H‐indoles as Novel 5‐HT6 Receptor Agonists.
2005
CARDIOVASCULAR IMPAIRMENT AND PHYSICAL WORKING CAPACITY IN CHILDREN WITH CHRONIC RENAL FAILURE1
1978
Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridines as Focal Adhesion Kinase Inhibitors
2013